|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone/growth factor
|
 |
|
Title:
|
 |
Structure of human activin a
|
|
Structure:
|
 |
Inhibin beta a chain. Chain: a, b. Synonym: activin beta-a chain, erythroid differentiation protein, edf. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: inhba. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.218
|
R-free:
|
0.259
|
|
|
Authors:
|
 |
A.E.Harrington,S.A.Morris-Triggs,B.T.Ruotolo,C.V.Robinson,S.Ohnuma, M.Hyvonen
|
Key ref:
|
 |
A.E.Harrington
et al.
(2006).
Structural basis for the inhibition of activin signalling by follistatin.
EMBO J,
25,
1035-1045.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
22-Aug-05
|
Release date:
|
07-Mar-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
25:1035-1045
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the inhibition of activin signalling by follistatin.
|
|
A.E.Harrington,
S.A.Morris-Triggs,
B.T.Ruotolo,
C.V.Robinson,
S.Ohnuma,
M.Hyvönen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The secreted, multidomain protein follistatin binds activins with high affinity,
inhibiting their receptor interaction. We have dissected follistatin's domain
structure and shown that the minimal activin-inhibiting fragment of follistatin
is comprised of the first and second Fs domains (Fs12). This protein can bind to
activin dimer and form a stable complex containing two Fs12 molecules and one
activin dimer. We have solved crystal structures of activin A alone and its
complex with Fs12 fragment to 2 A resolution. The complex structure shows how
Fs12 molecules wrap around the back of the 'wings' of activin, blocking the type
II receptor-binding site on activin A. Arginine 192 in Fs2 is a key residue in
this interaction, inserting itself in between activin's fingers. Complex
formation imposes a novel orientation for the EGF- and Kazal-like subdomains in
the Fs2 domain and activin A shows further variation from the canonical TGF-beta
family fold. The structure provides a detailed description of the inhibitory
mechanism and gives insights into interactions of follistatin with other
TGF-beta family proteins.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3 Overall architecture of the activin–Fs12 complex. (A)
View down the two-fold axis of symmetry showing the two
follistatin fragments binding to the back of the activin A
fingers. Activin protomers are coloured red and orange, the
interchain disulphide is shown in yellow. Follistatin domains
Fs1 and Fs2 are coloured blue and green, respectively. (B) A
perpendicular view of the complex showing the closed
conformation of activin and Fs12 fragments wrapping along the
activin A, shown as a surface model.
|
 |
Figure 6.
Figure 6 Interaction surface between activin and Fs12 and
ActRIIB. Comparison of activin binding by Fs12 and the
extracellular domain of the type II activin receptor (Greenwald
et al, 2004; PDB:1s4y). Activin protomers are shown as molecular
surfaces (orange and red), and the two Fs12 molecules (A, blue
Fs1 and green Fs2) and two type II receptor domains (B, blue and
green) are shown as ribbon diagrams. The activin surface is
coloured dark grey over atoms that are closer than 4 Å
from the interacting protein. Water molecules sandwiched between
the two proteins are shown as light blue spheres. Both complexes
are shown in the same orientation for the orange activin A
protomer.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
EMBO J
(2006,
25,
1035-1045)
copyright 2006.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Harjunmaa,
A.Kallonen,
M.Voutilainen,
K.Hämäläinen,
M.L.Mikkola,
and
J.Jernvall
(2012).
On the difficulty of increasing dental complexity.
|
| |
Nature,
483,
324-327.
|
 |
|
|
|
|
 |
R.Patani,
A.J.Hollins,
T.M.Wishart,
C.A.Puddifoot,
S.Alvarez,
A.R.de Lera,
D.J.Wyllie,
D.A.Compston,
R.A.Pedersen,
T.H.Gillingwater,
G.E.Hardingham,
N.D.Allen,
and
S.Chandran
(2011).
Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state.
|
| |
Nat Commun,
2,
214.
|
 |
|
|
|
|
 |
A.L.Blount,
K.Schmidt,
N.J.Justice,
W.W.Vale,
W.H.Fischer,
and
L.M.Bilezikjian
(2009).
FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription.
|
| |
J Biol Chem,
284,
7631-7645.
|
 |
|
|
|
|
 |
E.Kreidl,
D.Oztürk,
T.Metzner,
W.Berger,
and
M.Grusch
(2009).
Activins and follistatins: Emerging roles in liver physiology and cancer.
|
| |
World J Hepatol,
1,
17-27.
|
 |
|
|
|
|
 |
J.N.Cash,
C.A.Rejon,
A.C.McPherron,
D.J.Bernard,
and
T.B.Thompson
(2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
|
| |
EMBO J,
28,
2662-2676.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Nickel,
W.Sebald,
J.C.Groppe,
and
T.D.Mueller
(2009).
Intricacies of BMP receptor assembly.
|
| |
Cytokine Growth Factor Rev,
20,
367-377.
|
 |
|
|
|
|
 |
K.Tsuchida,
M.Nakatani,
K.Hitachi,
A.Uezumi,
Y.Sunada,
H.Ageta,
and
K.Inokuchi
(2009).
Activin signaling as an emerging target for therapeutic interventions.
|
| |
Cell Commun Signal,
7,
15.
|
 |
|
|
|
|
 |
M.A.Akinci,
H.Turner,
M.Taveras,
A.Barash,
Z.Wang,
P.Reinach,
and
J.M.Wolosin
(2009).
Molecular profiling of conjunctival epithelial side-population stem cells: atypical cell surface markers and sources of a slow-cycling phenotype.
|
| |
Invest Ophthalmol Vis Sci,
50,
4162-4172.
|
 |
|
|
|
|
 |
M.Asai-Coakwell,
C.R.French,
M.Ye,
K.Garcha,
K.Bigot,
A.G.Perera,
K.Staehling-Hampton,
S.C.Mema,
B.Chanda,
A.Mushegian,
S.Bamforth,
M.R.Doschak,
G.Li,
M.B.Dobbs,
P.F.Giampietro,
B.P.Brooks,
P.Vijayalakshmi,
Y.Sauvé,
M.Abitbol,
P.Sundaresan,
V.van Heyningen,
O.Pourquié,
T.M.Underhill,
A.J.Waskiewicz,
and
O.J.Lehmann
(2009).
Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes.
|
| |
Hum Mol Genet,
18,
1110-1121.
|
 |
|
|
|
|
 |
M.M.Phelan,
C.T.Thai,
D.C.Soares,
R.T.Ogata,
P.N.Barlow,
and
J.Bramham
(2009).
Solution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric Arrangement.
|
| |
J Biol Chem,
284,
19637-19649.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Patani,
A.Compston,
C.A.Puddifoot,
D.J.Wyllie,
G.E.Hardingham,
N.D.Allen,
and
S.Chandran
(2009).
Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity.
|
| |
PLoS One,
4,
e7327.
|
 |
|
|
|
|
 |
V.Veverka,
A.J.Henry,
P.M.Slocombe,
A.Ventom,
B.Mulloy,
F.W.Muskett,
M.Muzylak,
K.Greenslade,
A.Moore,
L.Zhang,
J.Gong,
X.Qian,
C.Paszty,
R.J.Taylor,
M.K.Robinson,
and
M.D.Carr
(2009).
Characterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION.
|
| |
J Biol Chem,
284,
10890-10900.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Deli,
E.Kreidl,
S.Santifaller,
B.Trotter,
K.Seir,
W.Berger,
R.Schulte-Hermann,
C.Rodgarkia-Dara,
and
M.Grusch
(2008).
Activins and activin antagonists in hepatocellular carcinoma.
|
| |
World J Gastroenterol,
14,
1699-1709.
|
 |
|
|
|
|
 |
A.L.Blount,
J.M.Vaughan,
W.W.Vale,
and
L.M.Bilezikjian
(2008).
A Smad-binding element in intron 1 participates in activin-dependent regulation of the follistatin gene.
|
| |
J Biol Chem,
283,
7016-7026.
|
 |
|
|
|
|
 |
K.Tsuchida,
M.Nakatani,
A.Uezumi,
T.Murakami,
and
X.Cui
(2008).
Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
|
| |
Endocr J,
55,
11-21.
|
 |
|
|
|
|
 |
O.Okhrimenko,
and
I.Jelesarov
(2008).
A survey of the year 2006 literature on applications of isothermal titration calorimetry.
|
| |
J Mol Recognit,
21,
1.
|
 |
|
|
|
|
 |
R.Esterberg,
J.M.Delalande,
and
A.Fritz
(2008).
Tailbud-derived Bmp4 drives proliferation and inhibits maturation of zebrafish chordamesoderm.
|
| |
Development,
135,
3891-3901.
|
 |
|
|
|
|
 |
R.Stamler,
H.T.Keutmann,
Y.Sidis,
C.Kattamuri,
A.Schneyer,
and
T.B.Thompson
(2008).
The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY.
|
| |
J Biol Chem,
283,
32831-32838.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Makanji,
K.L.Walton,
M.C.Wilce,
K.L.Chan,
D.M.Robertson,
and
C.A.Harrison
(2008).
Suppression of inhibin A biological activity by alterations in the binding site for betaglycan.
|
| |
J Biol Chem,
283,
16743-16751.
|
 |
|
|
|
|
 |
D.Weber,
A.Kotzsch,
J.Nickel,
S.Harth,
A.Seher,
U.Mueller,
W.Sebald,
and
T.D.Mueller
(2007).
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
|
| |
BMC Struct Biol,
7,
6.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.L.Zhang,
Y.Huang,
L.Y.Qiu,
J.Nickel,
and
W.Sebald
(2007).
von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms.
|
| |
J Biol Chem,
282,
20002-20014.
|
 |
|
|
|
|
 |
K.D.Kavanagh,
A.R.Evans,
and
J.Jernvall
(2007).
Predicting evolutionary patterns of mammalian teeth from development.
|
| |
Nature,
449,
427-432.
|
 |
|
|
|
|
 |
S.A.Morris,
A.D.Almeida,
H.Tanaka,
K.Ohta,
and
S.Ohnuma
(2007).
Tsukushi Modulates Xnr2, FGF and BMP Signaling: Regulation of Xenopus Germ Layer Formation.
|
| |
PLoS ONE,
2,
e1004.
|
 |
|
|
|
|
 |
T.F.Lerch,
M.Xu,
T.S.Jardetzky,
K.E.Mayo,
I.Radhakrishnan,
R.Kazer,
L.D.Shea,
and
T.K.Woodruff
(2007).
The structures that underlie normal reproductive function.
|
| |
Mol Cell Endocrinol,
267,
1-5.
|
 |
|
|
|
|
 |
T.F.Lerch,
S.Shimasaki,
T.K.Woodruff,
and
T.S.Jardetzky
(2007).
Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions.
|
| |
J Biol Chem,
282,
15930-15939.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.P.Wang,
M.Suomalainen,
S.Felszeghy,
L.C.Zelarayan,
M.T.Alonso,
M.V.Plikus,
R.L.Maas,
C.M.Chuong,
T.Schimmang,
and
I.Thesleff
(2007).
An integrated gene regulatory network controls stem cell proliferation in teeth.
|
| |
PLoS Biol,
5,
e159.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |